Member Info for ParanoiaBlue

http://www.investegate.co.uk/Article.aspx?id=201003240700100511J

“Serviced office group Regus continues to push higher after its upbeat statement yesterday and bullish comments from brokers today.” Looking on for now.

http://www.investegate.co.uk/Article.aspx?id=201003231335150333J

“Regus the outsourced workplaces provider, suffered a 41% fall in operating profit in 2009 with basic earnings per share down by the same amount to 7.1p. The shares rose by 13.3p to 100.5p. Revenues were slightly lower, down 2% to 1,055.1 million pounds, but strong cash generation and good growth prospects caused the firm to hike the dividend by 33% to 2.4p for the year. The firm added that its cost savings programme was ahead of schedule, with savings of 54.6 million pounds achieved so far. The average number of available workstations rose by 5.3% in the year to 161,455, and 45 new centres were opened in 2009, although this is only a third of the figure for 2008. Investec said that Regus was a clear leader in a growth market, and the broker has a buy stance and 150p target price on the firm.”

I agree to a certain extent. However, I’ve made significant money, here in the past. As I said the other week, if it drops below, or even around ,40p – I’ll buy a whole bunch more. Commodity-wise, there is a great potential, here. ATB

...worth a short.

http://www.investegate.co.uk/Article.aspx?id=201003221350539534I

See my post and link on 12th March, mate - Subject: "I believe GFM has +/- 40% interest." ATB

I have been in and out of this share, for quite while. If it drops below 30p, I may consider another punt. ATB to all those holding

“Fox-Davies Capital commented on Highland Gold and the recent 50% increase in its share price. It initially attributed the rise to an update which said that production had been at the top end of guidance, with the site at Belaya Gora in Russia beginning production in 2010. However, further investigation indicated that the rise was due to the fall in Russian bond yields indicating that Russian risks have diminished. The buy stance was repeated and the target price was raised to 146p. The shares finished 1.25p lower at 125.75p.”

http://www.investegate.co.uk/Article.aspx?id=201003180700047625I

"Cyprotex's results represent an impressive performance against a very difficult market currently for the pre-clinical CRO sector. Cyprotex continues to attract new customers, expand its offerings and is investing in new laboratories to service both the ADME and pre-clinical toxicology markets"

If it goes sub-40p, as mentioned last week, I’m going to buy a pile more, ATB

* Doubled number of strategic customers in 2009 (being customers contributing annual revenues in excess of £250,000 each) from three to six * Won over twenty new customers * Newly internally developed assays generated over £300,000 of revenues * Investment in laboratory space and state of the art mass spectrometer secured new strategic customer * Strategic alliance announced with Sygnature Chemical Services Limited, a leading provider of medicinal and computational chemistry services * Launched Cloe® Gateway, our new web based portal for access to Cyprotex services

http://www.investegate.co.uk/Article.aspx?id=201003170700096977I

..this one is a crock.... ATB

...picking up before tomorrow's statement.

http://www.investegate.co.uk/Article.aspx?id=201003160935136452I

Where did you get that news, mate?

Yes, I have a small amount, here. It has been fairly dormant, really. These take-over talks might be interesting. I was big across a few pharmas and related - ASM, BGC - but slowly selling off, as I expect a big market correction, before long. ATB